About Us


MBio Diagnostics provides rapid, on-the-spot testing solutions for our global commercial partners. Our portable LightDeck® platform delivers panels of lab-quality results in minutes for critical applications in health care, veterinary, food and environmental industries.

In addition to MBio’s experienced management team, the company’s technical team consists of a select group of instrumentation developers, biological assay scientists, and process engineers. MBio’s state-of-the-art facility in Boulder includes fully equipped biosafety laboratories for biological assay development, method development and validation. The facility also includes a 3750-sq. ft. cleanroom for pilot-scale cartridge production and cartridge manufacturing process development.

   Click here for the MBio Fact Sheet


Executive and Technical Leads


Christopher J. Myatt, Ph.D.
Chief Executive Officer


Michael J. Lochhead, Ph.D.
Chief Operating Officer


Sarah Bickman
Senior Scientist and Product Manager


Stephanie Butler
Director of Cartridge Manufacturing


Kathy Crawford
Director of Human Resources


Katie Erdley
Director of Quality Assurance


Tom Menhennett
Vice President of Engineering


Kevin Moll
Software Engineering Manager


Dan Nieuwlandt
Principal Scientist


Phil Papst
Scientist II


Laurene Thorson
Director of Process Engineering


Katie Todorof
Scientist II, Special Projects Manager

Board of Directors and Advisors


Christopher J. Myatt, Ph.D.
Chief Executive Officer

Dr. Myatt is the founder and CEO of MBio Diagnostics, Inc. Prior to MBio Diagnostics, Chris successfully founded and led Precision Photonics Corporation. Trained as a physicist and measurement scientist, Chris invented and developed multiple technologies that formed the basis of his companies.


Milton Chang, Ph.D.

Milton Chang, Ph.D., is an angel investor mentoring and advising entrepreneurs (www.incubic.com). He is the author of Toward Entrepreneurship (www.miltonchang.com). Dr. Chang has served on many boards, and was president/CEO of Newport and New Focus, taking both companies public.


Robert J. Silverman

Robert J. Silverman is a director and strategic advisor to the company. He previously served as the CEO of mtm laboratories AG, an in-vitro diagnostics company that developed and commercialized a portfolio of products for the early detection and diagnosis of cervical cancer.


Andy Drenick

Andy Drenick is Managing Director of Capital for Founders (CFF) LLC, which provides growth capital to founder-run businesses. Prior to founding CFF, Mr. Drenick was CEO of Qualmark Corporation, which sold to Espec Corporation in 2015.


Sally Hatcher
Corporate Secretary

Sally Hatcher, J.D. is a serial entrepreneur, advisor, startup accelerator faculty member, impact investor and board member. She regularly consults with diverse teams of innovators looking to spinout or start up a company.


Nick Traggis
Corporate Development

Mr. Traggis has held various leadership roles in both industrial manufacturing and technology development companies. Most recently, he has focused on technology transfer, contract negotiation, and M&A.